HIV/AIDS Care: The Minimum Package and Scaling Up

作者: Joia Mukherjee

DOI: 10.1007/978-0-387-72711-0_4

关键词:

摘要: As recently as 2002, experts argued that prevention should take priority over treatment for HIV/AIDS in Africa based on cost effectiveness considerations. However, analyses failed to into account arguably the most important reason implementing widespread HIV treatment—treating sick. Twenty years epidemic, fewer than 5% of people worldwide who required had access antiretroviral drugs (ARVs) (WHO, 2002). Additionally, many programs were failing and those successful not being taken scale. In unchecked spread mounting death toll among already infected serious effects communities heavily burdened by HIV; ranging from orphaning famine stigma professional burnout. Where it was available, therapy (ART) resulted a 80% reduction mortality Many efforts alone unlikely succeed high prevalence settings unless AIDS made available combined with evidence-based such use condoms, ART prevent maternal child transmission, sexually transmitted diseases, education linked knowledge one’s status. Activism, largely led living HIV, bring highly active retroviral (HAART) countries highest burden took center stage at International Society Durbin, South 2000. 2001, United Nations General Assembly Special Session called massive increases aid help poor cope

参考文章(41)
R Malombe, D Mbalume, W Zuza, A Bwanali, R Teck, R Chimzizi, A D Harries, F M Salaniponi, R Zachariah, F Gausi, P Gomani, Voluntary counselling, HIV testing and adjunctive cotrimoxazole are associated with improved TB treatment outcomes under routine conditions in Thyolo District, Malawi. International Journal of Tuberculosis and Lung Disease. ,vol. 8, pp. 579- 585 ,(2004)
P. M. Pronyk, J. R. Hargreaves, J. D. Porter, B. Makhubele, K. A. Rowe, H. P. Hausler, Adherence to TB preventive therapy for HIV-positive patients in rural South Africa: implications for antiretroviral delivery in resource-poor settings? International Journal of Tuberculosis and Lung Disease. ,vol. 9, pp. 263- 269 ,(2005)
Pablo Gottret, George Schieber, Health Financing Revisited: A Practitioner's Guide ,(2006)
Catherine Orrell, David R. Bangsberg, Motasim Badri, Robin Wood, Adherence is not a barrier to successful antiretroviral therapy in South Africa. AIDS. ,vol. 17, pp. 1369- 1375 ,(2003) , 10.1097/00002030-200306130-00011
S Day, Uptake of HIV testing in patients with a confirmed sexually transmitted infection Sexually Transmitted Infections. ,vol. 78, pp. 389- a ,(2002) , 10.1136/STI.78.5.389-A
Richard H. Kahn, Kera E. Moseley, John N. Thilges, Gwendolyn Johnson, Thomas A. Farley, Community-based screening and treatment for STDs: results from a mobile clinic initiative. Sexually Transmitted Diseases. ,vol. 30, pp. 654- 658 ,(2003) , 10.1097/01.OLQ.0000083892.66236.7A
Louise Kuhn, Anna Coutsoudis, Derseree Moodley, Daria Trabattoni, Nolwandle Mngqundaniso, Gene M Shearer, Mario Clerici, Hoosen M Coovadia, Zena Stein, None, T-helper cell responses to HIV envelope peptides in cord blood: protection against intrapartum and breast-feeding transmission. AIDS. ,vol. 15, pp. 1- 9 ,(2001) , 10.1097/00002030-200101050-00003
Sheri Weiser, William Wolfe, David Bangsberg, Ibou Thior, Peter Gilbert, Joseph Makhema, Poloko Kebaabetswe, Dianne Dickenson, Kgosidialwa Mompati, Max Essex, Richard Marlink, Barriers to antiretroviral adherence for patients living with HIV infection and AIDS in Botswana. Journal of Acquired Immune Deficiency Syndromes. ,vol. 34, pp. 281- 288 ,(2003) , 10.1097/00126334-200311010-00004
David R. Bangsberg, Frederick M. Hecht, Edwin D. Charlebois, Andrew R. Zolopa, Mark Holodniy, Lewis Sheiner, Joshua D. Bamberger, Margaret A. Chesney, Andrew Moss, Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS. ,vol. 14, pp. 357- 366 ,(2000) , 10.1097/00002030-200003100-00008
David Wilkinson, Nomsa Wilkinson, Carl Lombard, Des Martin, Alan Smith, Katherine Floyd, Ron Ballard, On-site HIV testing in resource-poor settings: Is one rapid test enough? AIDS. ,vol. 11, pp. 377- 381 ,(1997) , 10.1097/00002030-199703110-00016